fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

NICE (UK) terminated appraisal for Onivyde (pegylated liposomal irinotecan) in combination for untreated metastatic pancreatic cancer – Servier

Written by | 13 May 2025

NICE (UK) is unable to make a recommendation about the use in the NHS of pegylated liposomal irinotecan plus oxaliplatin, 5-fluorouracil and leucovorin for untreated metastatic pancreatic cancer… read more.

NICE (UK) positive for Lonsurf (tifluridine–tipiracil) + Avastin (bevacizumab) to treat colorectal cancer – Servier

Written by | 4 Oct 2024

Trifluridine–tipiracil with bevacizumab is NICE  recommended, within its marketing authorisation, for treating metastatic colorectal cancer in adults who have had 2 lines of treatment (including fluoropyrimidine-, oxaliplatin- and irinotecan-based… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.